FEATURED ARTICLE

The Problem of Pain

Chronic pain affects over 1.5 billion people globally, with traditional medications often causing significant side effects. coMra therapy presents a safer alternative by combining laser therapy with magnetism, ultrasound, and…

Read this article
The Problem of Pain
Browse our blog and see all articles

Customer services

Our customer services team are seasoned practitioners of coMra therapy with over a decade of experience.

If you're considering a coMra device – but have questions not covered in our extensive Resources and FAQ pages – please send us an email and we'll get back to you soonest:

info@comra-therapy.com

User support

If you already own a coMra device and need help with your device, with your treatments – or with any technical issues – please reach out to us here.

Click through on the link below, send us an email and we'll get back to you:

support@comra-therapy.com

Schedule a call

If you'd rather speak with one of our experienced customer service team members, you can schedule a call with us instead.

Please click through on the Calendly link below and one of our customer service team will get back to you:

calendly.com/comra-support-team

Chat with us

Alternatively, our customer service team are on hand to answer your queries between 9:00–5:00 EST.

Please click through on the link below, or simply click the floating Chat icon on the bottom right of the screen.

Chat with customer services now!
WARRANTY

Register your coMra device!

If you recently purchased one of our coMra devices, welcome to the family! Please fill out the registration form below to activate your warranty.

How do I find my serial number? Found on the sticker on the back of your original product box.

Case Study: Central Retinal Artery Occlusion Treatment with coMra Therapy

Patient Information

  • Age: 71 years old
  • Gender: Female
  • Condition: Central retinal artery occlusion in left eye

Initial Symptoms (May 8, 2014)

  • Sudden dark cloud over left eye with complete vision loss
  • Partial clearing after a few days, turning into a pink cloud
  • Complete loss of depth perception
  • Extreme dizziness with eye or head movements
  • Reduced color vision, especially red
  • Overwhelmed in complex visual environments
  • Poor eye coordination

Medical History

  • Glaucoma
  • Hypertension
  • Thyroid problems
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Osteoporosis
  • LASIK surgery in both eyes (many years ago)

Initial Examination (3 weeks after onset)

  • Best corrected vision: 20/50 (with head turned left)
  • Poor contrast sensitivity in right eye, unable to test left eye
  • Impaired color vision in right eye, no color vision in left eye
  • No stereopsis (3D vision)
  • Using three different canes for walking

Treatment Protocol

  • 6 sessions of coMra therapy, once a week
  • Universal 1 protocol plus optic neuritis treatment:
  • 2 minutes at the temple
  • Scanning over eye, above and below
  • 1 minute lateral aspect of each eye
  • Through closed eyelid and eye in adduction

Results After First Treatment

  • Significant improvement in balance and dizziness
  • Vision in left eye improved from 20/30+2 to 20/40

Results After 6 Treatments

  • Improved maneuverability, especially in tight spots
  • Virtually no dizziness with eye movements
  • Reduced visual overwhelm
  • Rarely using cane, almost normal balance
  • Improved eye coordination
  • Visual acuity:
  • Right eye: 20/25-1
  • Left eye: 20/40
  • Contrast sensitivity improved in both eyes
  • Color vision significantly improved
  • Stereopsis present (200 arc seconds)

One-Year Follow-up

  • Ophthalmologist noted surprising lack of cellular degeneration
  • Cloud still present but can be shifted
  • Driving locally
  • Visual acuity:
  • Right eye: 20/30+2
  • Left eye: 20/30-2
  • Stereopsis improved to 160 arc seconds

Conclusion

  • Visual improvements generally maintained
  • Recommendation for continued coMra therapy for glaucoma management

This case study demonstrates the potential of coMra therapy in treating central retinal artery occlusion, showing significant improvements in vision, balance, and overall quality of life for the patient.